Search Results
Nov 12, 2025, 06:00 ET Boyd Group Services Inc. Reports Third Quarter 2025 Results
announced the results for the three and nine month periods ended September 30, 2025. The Boyd Group's third quarter 2025 financial statements and MD&A have been filed on SEDAR+ (www.sedarplus.ca) and EDGAR (www.sec.gov).
More news about: Boyd Group Services Inc.
Nov 12, 2025, 05:00 ET VISTAJET LAUNCHES THE SLEEP PROGRAM -- A SCIENCE-BACKED APPROACH TO REST AND RECOVERY AT ALTITUDE AND AT DESTINATION
Developed in collaboration with longevity and health expert Peter Attia, MD — Founder of Early Medical, bestselling author and host of The Drive podcast — alongside VistaJet's in-house nutritionist and a team
More news about: VistaJet
Nov 12, 2025, 03:00 ET AbolerIS Pharma Announces Publication in Molecular Therapy Cell Press Journal of New Preclinical Results Supporting Mechanism of Action of ABO21009, a First-in-Class Anti-CD45RC Antibody, Currently in Phase 1
dosing of healthy volunteers under an authorized Clinical Trial Application (CTA) for a first-in-human Phase 1 study of ABO21009. Dr. Ronald van Brempt, MD, CMO of AbolerIS, mentions that a milestone has been reached. "Building on the highly encouraging safety and PK/PD results of the healthy volunteer part
More news about: AbolerIS Pharma
Nov 12, 2025, 02:00 ET Flexibility, quality, and sustainability to shape India's workplace revolution in 2026: Colliers
https://mma.prnewswire.com/media/2820909/Arpit_Mehrotra_MD_OS_Colliers.jpgLogo:
More news about: Colliers
Nov 11, 2025, 17:00 ET Mountain Province Diamonds Announces Third Quarter Financial Results for 2025
EBITDA are non-IFRS measures with no standardized meaning prescribed under IFRS. See the Non-IFRS Measures section of the Company's September 30, 2025 MD&A for explanation and reconciliation.
More news about: Mountain Province Diamonds Inc.
Nov 11, 2025, 16:14 ET CAE reports second quarter fiscal 2026 results
support solutions as well as material assumptions contained in this press release, quarterly Management's Discussion and Analysis (MD&A) and in CAE's fiscal 2025 MD&A, all available on our website (
More news about: CAE Inc.
Nov 11, 2025, 15:25 ET WeNatal Reinvents Prenatal Nutrition with the First 3-in-1 Protein Powder for Fertility, Pregnancy & Postpartum
born from their own experiences with pregnancy loss and a desire to shift the fertility journey from "me" to "we." All WeNatal products are MD-formulated, third-party tested, and designed to simplify wellness with allergen-free, clinically informed nutrition. Recognized by Dr. Mark Hyman, Kelly LeVeque,
More news about: WeNatal
Nov 11, 2025, 15:02 ET Silent Beacon Expands Its Safety Line with Personal Safety Alarm - Now Available for Preorder
ROCKVILLE, Md., Nov. 11, 2025 /PRNewswire/ -- Silent Beacon, a leader in wearable safety technology, today announced the upcoming launch of the Silent Beacon Personal Safety Alarm, a compact,
More news about: Silent Beacon
Nov 11, 2025, 14:05 ET KMX INVESTOR DEADLINE: CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
2, 2026 to seek appointment as lead plaintiff of the CarMax class action lawsuit. Captioned Cap v. CarMax, Inc., No. 25-cv-03602 (D. Md.), the CarMax class action lawsuit charges CarMax as well as certain of CarMax' top executives with violations of the Securities Exchange Act of
More news about: Robbins Geller Rudman & Dowd LLP
Nov 11, 2025, 13:21 ET Dr. Rod J. Rohrich Named One of the Best Plastic Surgeons in Dallas by D Magazine
contributions to education and research. Contact Rod J. Rohrich, MD, FACSDallas Plastic Surgery Institute9101 N Central Expy #600, Dallas, TX 75231Office: (214) 821-9114
More news about: Dr. Rod J. Rohrich
Nov 11, 2025, 12:00 ET Lapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0
"Collaboration is crucial to innovation, and this partnership exemplifies that," said Jhonatan Bringas Dimitriades, MD, CEO and Co-Founder of Lapsi Health. "This strategic step positions Keikku as one of the most powerful medical companion tools. By combining Keikku's
More news about: Lapsi Health
Nov 11, 2025, 11:51 ET MagMutual Introduces MyDefense™: Defining the New Standard of Malpractice Defense for Healthcare Providers
counsel. "MyDefense equips providers with resources that go beyond what any other insurer can offer," said William S. Kanich, MD, JD, Executive Chairperson. About MagMutual For more than four decades, MagMutual
More news about: MagMutual
Nov 11, 2025, 11:11 ET Breakthrough Insights into Hemodynamics Featured in Journal of Cardiac Failure November Issue
grateful for the exceptional work of our guest editors whose expertise and vision shaped this comprehensive issue," co-editor-in-chief and Anuradha Lala, MD continued. "We encourage readers to engage with the full set of articles, which provide diverse and thought-provoking perspectives on this rapidly advancing
More news about: Heart Failure Society of America
Nov 11, 2025, 10:16 ET AI-Based Analysis of CT Scans Taken for Many Reasons May Also Reveal Weakened Bones
by NYU Langone Health. Besides Bredella and Gyftopoulos, NYU Langone study co-investigators are Bari Dane, MD, Emilio Vega, RT, and Michael Recht, MD. Recht is the Louis Marx Professor of Radiology and chair of the Department of Radiology at the NYU Grossman School of Medicine.
More news about: NYU Langone Health System
Nov 11, 2025, 10:13 ET Olympus Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business
people's lives healthier, safer and more fulfilling, announced today the appointments of Dr. Thomas R. Gildea, MD, MS, FCCP, as Global Lead, Medical Affairs, Respiratory, and Dr. Tamás Ötvös, MD as Global Clinical Lead and Director of Clinical Research, Respiratory, within the Medical & Scientific Affairs
More news about: Olympus Corporation of the Americas
Nov 11, 2025, 10:10 ET OneOncology and Cancer Specialists of North Florida Partner to Improve Community Based Cancer Care in Jacksonville and North Florida Communities
Florida is a leading cancer care provider in Northeast Florida, and we are thrilled to welcome them to the OneOncology platform," said Jeff Patton, MD, CEO, OneOncology. "We look forward to working with our new partners to help their practice grow, add services along the continuum of care to their clinics
More news about: OneOncology, LLC.
Nov 11, 2025, 09:18 ET Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
seclidemstat, the company's lead candidate, which is being studied in an investigator-initiated Phase 1/2 clinical study in hematologic cancers underway at MD Anderson Cancer Center as a potential treatment for MDS) and chronic myelomonocytic leukemia (CMML) in patients with limited treatment options. SP-3164,
More news about: Salarius Pharmaceuticals, Inc.
Nov 11, 2025, 09:03 ET MD Integrations Extends Virtual Care Platform to E-Commerce
mdintegrations.com/ecommerce About MD Integrations MD Integrations (MDI) powers digital health brands with the technology and physician network to launch and scale compliant
More news about: MD Integrations
Nov 11, 2025, 09:00 ET The Lake Como EDITION Debuts on Italy's Most Iconic Shoreline, Bringing New-Era Luxury to the Legendary Destination
region long defined by classical grandeur. BETHESDA, Md., Nov. 11, 2025 /PRNewswire/ -- Lake Como, with its placid turquoise waters surrounded by towering, sharp-peaked
More news about: Marriott International, Inc.
Nov 11, 2025, 08:58 ET iLeukon Therapeutics Presents Phase I Data for ILKN421H at SITC 2025
presented during a Late-Breaking Clinical Oral Session at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, MD. The study evaluates ILKN421H, a lipid-nanoparticle (LNP)-formulated mRNA encoding a non-α HSA–IL-2 variant (IL-2v), as monotherapy
More news about: iLeukon Therapeutics
Nov 11, 2025, 08:41 ET Brave Kids Publishing Releases The King's Race, a Heartwarming Story about Celebrating Differences by First-Time Children's Author Dr. Eyal Levit, an Associate Professor of Dermatology at Columbia and Mount Sinai Hospitals
BETHESDA, Md., Nov. 11, 2025 /PRNewswire/ -- Brave Kids Publishing, an imprint of Brave Healer Publishing, is proud to announce the release of
More news about: Brave Kids Publishing
Nov 11, 2025, 08:30 ET Becoming a sponsor of choice for high-performing sites, Upcoming Webinar Hosted by Xtalks
ICON; Manual Rodriguez, MD, Principal Investigator, ICON; and Mary Pevear, Director, Clinical Trial Management, Kura Oncology, for the live webinar on Wednesday, December 3, 2025,
More news about: Xtalks
Nov 11, 2025, 08:25 ET Repairon Announces Positive Clinical Outcomes of Engineered Heart Muscle as Reparative Therapy for Advanced Heart Failure Reported at the Scientific Sessions of the American Heart Association
human engineered heart muscle as biological ventricular assist tissue (BioVAT) transplants in patients with advanced heart failure. Wolfram Zimmermann, MD, professor and director of the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen, Germany, presented the first-in-patient,
More news about: Repairon GmbH
Nov 11, 2025, 08:07 ET CND Life Sciences' Syn-One® Biomarker Services Used for Novel Parkinson's Disease Endpoint in Phase 2 Drug Trial
are encouraged by the preliminary data generated using our Syn-One Biomarker Services in ABLi's 201 Trial for risvodetinib," said Christopher Gibbons, MD, chief scientific officer of CND. "While additional work needs to be done in future trials, these results support the potential role Syn-One can play
More news about: CND Life Sciences
Nov 11, 2025, 08:01 ET Expanse Medical Expands to Providence, Rhode Island with Support from the Rhode Island Life Science Hub
"We are proud to support Expanse as they bring transformative capabilities and new ventures to Rhode Island," said Mark A. Turco, MD, President and CEO of RILSH. "The company's decision to grow here reflects Rhode Island's momentum as a destination for high-growth life science companies.
More news about: Expanse Medical